Patents by Inventor Peter M. Schantz

Peter M. Schantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolation of diagnostic glycoproteins to taenia solium, immunoblot-assay and method for the detection of human cysticercosis
    Patent number: 5354660
    Abstract: The present invention is directed to a method and a kit for diagnosing active human neurocysticercosis utilizing an immunoblot assay which comprises:detecting the presence of antibodies in the serum or cerebrospinal fluid of a human to be diagnosed, wherein the antibodies are reacted with Taenia solium larval antigens which have been isolated by lentil lectin affinity. The larval antigens are designated GP50, GP42, GP24, GP21, GP18, GP14, and GP13, wherein GP indicates that said antigen is a glycoprotein and the number indicates the molecular weight in K daltons, as determined by SDS-PAGE.
    Type: Grant
    Filed: April 2, 1992
    Date of Patent: October 11, 1994
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Victor C. W. Tsang, Joy A. Brand, Anne E. Boyer, Marianna Wilson, Peter M. Schantz, Shirley E. Maddison